🇺🇸 Vertex Pharmaceuticals Incorporated
Forum topic · VRTX · Company page: financials, ownership and filings
Join the discussion on Vertex Pharmaceuticals Incorporated
Loading…
Results announced on 2 November 2026
Vertex Pharmaceuticals Incorporated announced results on 2 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: revenue of $3.4 billion (up 12% from a year earlier) and net income of $654 million (down 40% from a year earlier).
Mutual funds: 954 funds hold $60.9 billion
954 mutual funds in 3 countries hold shares of Vertex Pharmaceuticals Incorporated worth $60.9 billion, about 50.0% of the company (funds' newest reports, up to 31 October 2026).
Since their previous reports 385 funds added shares and 472 sold; on balance they sold $556 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.